Dual Chamber Prefilled Syringes Market In-depth Analysis, Share, Company Profile

Posted by Arslan on August 20th, 2019

According to Fact.MR’s recently collated research report, a spectacular growth has been envisaged for the global dual chamber prefilled syringes market in the forecast period (2017-2026). Worldwide sales of dual chamber prefilled syringes are poised to bring in approximately US$ 3,300 Mn revenues by 2026-e. With continuous evolution of the healthcare sector, keeping a record of latest developments and trends is fundamental for dual chamber prefilled syringes manufacturers to formulate key business strategies. Detailed insights about raw material sourcing, supply chain, regulatory approvals, pricing analysis, list of distributors, and cost structure are provided in this section. Dual chamber prefilled syringes have evolved to the stage where they are functionally useful for the packaging of lyophilized small volume parental drugs.

A CAGR of 8.7% has been projected for the global dual chamber prefilled syringes market during the forecast period, 2017 to 2026, according to a new study of Fact.MR. Roughly US$ 3,300 Mn worth of dual chamber prefilled syringes are likely to be sold across the globe by 2026-end.

For More Details - A sample of this report is available upon request here -

https://www.factmr.com/connectus/sample?flag=S&rep_id=486

Key Takeaways from Fact.MR’s Report on Dual Chamber Prefilled Syringes Market for Forecast Period 2017-2026

• Sales of dual chamber prefilled syringes are expected to record the fastest expansion in online pharmacies through 2026, trailed by retail pharmacies that will account for a relatively larger market revenue share than online pharmacies by 2026-end.
• In terms of revenues, hospital pharmacies will continue to be the leading contributor to the global dual chamber prefilled syringes market.
• Based on product material, glass prefilled syringes are anticipated to remain sought-after in the market, with sales projected to exceed US$ 2,000 Mn in revenues by 2026-end. Plastic prefilled syringes will exhibit a relatively higher CAGR in the market through 2026.
• On the basis of product type, conventional prefilled syringes are expected to account for the lion’s share of the market during 2017 to 2026. Safety prefilled syringes will account for nearly 30% revenue share of the market through the forecast period.
• North America is likely to prevail as the fast-expanding as well as the most lucrative market for dual chamber prefilled syringes, followed by Europe. Asia-Pacific excluding Japan (APEJ) will also account for a major chunk of the market’s revenue share during the forecast period.

Prefilled syringes have gained popularity owing to enhanced user safety, ease of use and the decline of potential dosage errors. At-home administration, self-administration and the surge of biologics are the primary aspects that trigger the growth of dual chamber prefilled syringes market. On account of low cost and adoption of self-administered drugs, conventional prefilled syringes are expected to be most preferred products in the market. Meanwhile, prefilled has become integral part of auto-injection segment of the drug delivery market, which needs prefilled cartridges.

Dual Chamber Prefilled Syringes Market: Overview

The report provides a comprehensive assessment on the dual chamber prefilled syringes market with quantitative and qualitative analysis. Further, the report offers a clear picture with respect to dynamics of dual chamber prefilled syringes market, including drivers, trends, opportunities, and restraints. These aspects are indispensable and possess potency to impact the growth of the dual chamber prefilled syringes market. Besides, the report delves into the segregation of the dual chamber prefilled syringes market to provide a robust picture of dual chamber prefilled syringes market.

Competitive Landscape

With trend toward surging adoption of self-injection syringes, and development of technologically advanced dual chamber prefilled syringes, leading players in the market are concentrating on expansion of their product portfolio and the market reach. In this highly competitive and rapidly evolving market, players are emphasizing on the essentiality of up-to-date information for monitoring their performance and making critical decisions regarding profitability & growth.

Some players in the market are also focusing on making improvements in design of dual chamber prefilled syringes for improving stability and safety of sensitive drugs. Fact.MR’s report has listed key players augmenting the market expansion, which include Bespak Europe Ltd, Catalent, Inc., Credence MedSystems, Inc., Otsuka America Pharmaceutical, Inc., Schott AG, West Pharmaceutical Services, Inc., Ypsomed Holding AG, Gerresheimer AG, Vetter Pharma-Fertigung GmbH & Co. KG, Nipro Corporation, Boehringer Ingelheim GmbH, Amgen Inc., and Pfizer Inc.